Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larson, A. W.
Right arrow Articles by Shih, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larson, A. W.
Right arrow Articles by Shih, J. C.
NEUROLOGY 1978;28:824
© 1978 American Academy of Neurology

Posttraumatic epilepsy and acute intermittent porphyria

Effects of phenytoin, carbamazepine, and clonazepam

Alan W. Larson, M.D., William R. Wasserstrom, M.D., Bertram F. Felsher, M.D. and Joyce C. Shih, M.S.

Departments of Medicine and Neurology, Veterans Administration Hospital, Long Beach, California, and the University of California, Irvine, School of Medicine, Irvine, California.

A patient with uncontrolled posttraumatic epilepsy and acute intermittent prophyria was subjected to successive therapeutic trials with phenytoin, carbamazepine, and clonazepam, while eating an adequate diet. Both phenytoin and carbamazepine treatments caused significant increases in porphobilinogen excretion and appeared to induce acute porphyric attacks. In contrast, treatment with clonazepam under rigid dietary control for 10 days caused no increase in porphobilinogen excretion. During the subsequent 7 months of treatment with clonazepam, neither seizures nor porphyric attacks recurred. These findings suggest that clonazepam may be a safe and effective treatment for chronic or severe generalized seizure disorders in patients with acute intermittent porphyria.

Reprint requests should be addressed to Dr. Felsher, Hepatology Section, Veterans Administration Hospital, 5901 E. 7th Street, Long Beach, CA 90822.

This investigation was supported in part by the Medical Research Programs of the Veterans Administration.

Accepted for publication December 28, 1977.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by AAN Enterprises, Inc.